Skip to main content
. 2021 Apr 26;21:75. doi: 10.1186/s12880-021-00605-4

Fig. 3.

Fig. 3

Survival analysis (DFS) for postoperative patients using adjuvant chemotherapy with S-1 in the validation cohort (K–M method). Grouping by T1WI_NGTDM_Strength (a) and tumour location (b) both prompted marginally different postoperative DFS between the respective subgroups